| Assessment of potential bias in research grant peer review in Canada R Tamblyn, N Girard, CJ Qian, J Hanley Cmaj 190 (16), E489-E499, 2018 | 159 | 2018 |
| Pneumonia risk in asthma patients using inhaled corticosteroids: a quasi‐cohort study CJ Qian, J Coulombe, S Suissa, P Ernst British journal of clinical pharmacology 83 (9), 2077-2086, 2017 | 58 | 2017 |
| Integrated health information technology and the quality of patient care: A natural experiment A Pinsonneault, S Addas, C Qian, V Dakshinamoorthy, R Tamblyn Journal of Management Information Systems 34 (2), 457-486, 2017 | 54 | 2017 |
| Short-acting beta-2-agonist exposure and severe asthma exacerbations: SABINA findings from Europe and North America JK Quint, S Arnetorp, JWH Kocks, M Kupczyk, J Nuevo, V Plaza, ... The Journal of Allergy and Clinical Immunology: In Practice 10 (9), 2297 …, 2022 | 44 | 2022 |
| Improving patient safety and efficiency of medication reconciliation through the development and adoption of a computer-assisted tool with automated electronic integration of … R Tamblyn, N Winslade, TC Lee, A Motulsky, A Meguerditchian, M Bustillo, ... Journal of the American Medical Informatics Association 25 (5), 482-495, 2018 | 35 | 2018 |
| Comprehensive genomic profiling for non-small-cell lung cancer: health and budget impact KM Johnston, BS Sheffield, S Yip, P Lakzadeh, C Qian, J Nam Current Oncology 27 (6), 569-577, 2020 | 19 | 2020 |
| What is in your wallet? A cluster randomized trial of the effects of showing comparative patient out-of-pocket costs on primary care prescribing for uncomplicated hypertension R Tamblyn, N Winslade, CJ Qian, T Moraga, A Huang Implementation Science 13, 1-14, 2018 | 18 | 2018 |
| SABA use as an indicator for asthma exacerbation risk: an observational cohort study (SABINA Canada) SG Noorduyn, C Qian, KM Johnston, M Soliman, M Talukdar, BL Walker, ... ERJ Open Research 8 (3), 2022 | 15 | 2022 |
| Costs of in-house genomic profiling and implications for economic evaluation: A case example of non-small cell lung cancer (NSCLC) KM Johnston, BS Sheffield, S Yip, P Lakzadeh, C Qian, J Nam Journal of Medical Economics 23 (10), 1123-1129, 2020 | 15 | 2020 |
| Treatment patterns and costs among patients with OAB treated with combination oral therapy, sacral nerve stimulation, percutaneous tibial nerve stimulation, or … SR Kraus, A Shiozawa, SM Szabo, C Qian, B Rogula, J Hairston Neurourology and Urodynamics 39 (8), 2206-2222, 2020 | 9 | 2020 |
| Characterizing demographics, comorbidities, and costs of care among populations with Duchenne muscular dystrophy with Medicaid and commercial coverage AC Klimchak, SM Szabo, C Qian, E Popoff, S Iannaccone, KL Gooch Journal of managed care & specialty pharmacy 27 (10), 1426-1437, 2021 | 6 | 2021 |
| Characterizing the occurrence of key clinical milestones in Duchenne muscular dystrophy in the united states using real-world data SM Szabo, AC Klimchak, C Qian, S Iannaccone, E Popoff, KL Gooch Journal of Neuromuscular Diseases 9 (6), 689-699, 2022 | 4 | 2022 |
| PRO121 the use of real-world data in health technology assessment of medications for rare diseases M Harwood, A Deighton, A Mickle, C Qian, S Szabo Value in Health 22, S863, 2019 | 3 | 2019 |
| SABA overreliance and physician visits in Canada S Noorduyn, M Soliman, K Johnston, Q Christina, P Hernandez, E Penz European Respiratory Journal 56 (suppl 64), 2020 | 2 | 2020 |
| Assessment of potential bias in research grant peer review in Canada. CMAJ 190: E489–E499 R Tamblyn, N Girard, CJ Qian, J Hanley | 2 | 2018 |
| Rate of admission and readmission to the emergency department (ED) associated with physician visits among patients with asthma I Mayers, S Noorduyn, A Randhawa, M Soliman, M Talukdar, C Qian, ... European Respiratory Journal 60 (suppl 66), 2022 | 1 | 2022 |
| Treatment patterns of patients with chronic obstructive pulmonary disease (COPD) in Ontario, Canada K Johnston, C Qian, M Soliman, S Noorduyn, E Penz European Respiratory Journal 58 (suppl 65), 2021 | 1 | 2021 |
| Exacerbations in chronic obstructive pulmonary disease (COPD) in Ontario, Canada S Noorduyn, M Soliman, C Qian, K Johnston, E Penz European Respiratory Journal 58 (suppl 65), 2021 | 1 | 2021 |
| PPM5 costs of in-house mutational-testing and implications for economic evaluation: a case example of non-small cell lung cancer (NSCLC) J Nam, P Lakzadeh, K Johnston, S Yip, C Qian, B Sheffield Value in Health 22, S837-S838, 2019 | 1 | 2019 |
| PPM4 Comprehensive genomic profiling for non-small cell lung cancer (NSCLC): a health and budget impact analysis J Nam, K Johnston, S Yip, C Qian, P Lakzadeh, B Sheffield Value in Health 22, S837, 2019 | 1 | 2019 |
